InvestorsHub Logo
Followers 101
Posts 13472
Boards Moderated 2
Alias Born 01/23/2004

Re: big orange post# 7638

Friday, 01/06/2017 3:29:31 PM

Friday, January 06, 2017 3:29:31 PM

Post# of 12606
It will not be competitive in price.

Since naletrexone has been around for a long time how competitive in price can the new product be compared to the tablet form of naletrexone? Generally speaking a tablet form of a generic that has been around for a long time is absolutely dirt cheap.



Where it will have a market edge over tablet naltrexone is that patient compliance will significantly increase.

Since the BICX new version will be deliver by injection rather than by surgery the chance to get an insurance company to reimburse for the injection should be much easier.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BICX News